Merit Medical Systems' Q1 2024 performance exceeded analyst expectations in both earnings per share and sales, indicating a positive outlook for the company. This outperformance, especially when it surpasses estimates by a significant margin, is likely to instill confidence among investors and could lead to a short-term uptick in the stock price. The year-over-year sales growth of 8.72% further underscores the company's growth trajectory, making it an attractive asset for investors.